Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin-10 receptor subunit beta (IL10RB) is a single-pass type I transmembrane protein that serves as a shared accessory subunit for several class II cytokine receptor complexes. It is essential for mediating signal transduction for interleukin-10 (IL-10), interleukin-22 (IL-22), interleukin-26 (IL-26), and type III interferons. Upon ligand binding, IL10RB associates with other receptor subunits (such as IL10RA or IFNLR1) to form a functional heterotetrameric complex, which activates downstream Janus kinase 1 (JAK1) and tyrosine kinase 2 (TYK2) signaling pathways, leading to STAT3 phosphorylation and the transcription of anti-inflammatory or antiviral genes. IL10RB plays a critical role in maintaining immune homeostasis, particularly in mucosal tissues like the gastrointestinal tract. Loss-of-function mutations in the IL10RB gene are strongly associated with very early-onset inflammatory bowel disease (VEO-IBD) and severe enterocolitis in infants. In therapeutic development, IL10RB is targeted by recombinant cytokines and fusion proteins, such as pegilodecakin and AMT-101, which act as agonists to harness the anti-inflammatory properties of IL-10 for treating autoimmune diseases or to stimulate CD8+ T-cell-mediated antitumor immunity in oncology.
Agonism of the receptor complex to activate downstream JAK/STAT signaling, promoting anti-inflammatory pathways or stimulating CD8+ T-cell-mediated antitumor immunity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-10 receptor subunit beta (IL10RB).